Articles published by Ultragenyx Pharmaceutical Inc.
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 20, 2024
Via GlobeNewswire
Tickers
RARE
Via GlobeNewswire
Tickers
RARE
Ultragenyx to Host Conference Call for Third Quarter 2024 Financial Results and Corporate Update
October 29, 2024
Via GlobeNewswire
Tickers
RARE
Via GlobeNewswire
Tickers
RARE
Ultragenyx Announces Upcoming Setrusumab (UX143) Presentations at the ASBMR 2024 Annual Meeting
September 26, 2024
Via GlobeNewswire
Tickers
RARE
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 18, 2024
Via GlobeNewswire
Tickers
RARE
Ultragenyx to Participate in Investor Conferences in September
August 29, 2024
Via GlobeNewswire
Tickers
RARE
Via GlobeNewswire
Tickers
RARE
Via GlobeNewswire
Tickers
RARE
Via GlobeNewswire
Tickers
RARE
Via GlobeNewswire
Tickers
RARE
Ultragenyx Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
June 13, 2024
Via GlobeNewswire
Tickers
RARE
Via GlobeNewswire
Tickers
RARE
Via GlobeNewswire
Via GlobeNewswire
Tickers
RARE
Via GlobeNewswire
Tickers
RARE
Via GlobeNewswire
Tickers
RARE
Via GlobeNewswire
Tickers
RARE
Via GlobeNewswire
Tickers
RARE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.